购物车
- 全部删除
- 您的购物车当前为空
Aβ42-IN-1 free base是一种口服活性的γ-secretase调节剂,具有高暴露度。该化合物能显著降低小鼠脑中Aβ42的水平,IC50为0.091 μM,显示出在阿尔茨海默病研究中的潜力。
Aβ42-IN-1 free base是一种口服活性的γ-secretase调节剂,具有高暴露度。该化合物能显著降低小鼠脑中Aβ42的水平,IC50为0.091 μM,显示出在阿尔茨海默病研究中的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Aβ42-IN-1 free base (compound 1v), an orally active γ-secretase modulator with high brain exposure, effectively lowers Aβ42 levels, exhibiting an IC 50 of 0.091 μM, and significantly diminishes brain Aβ42 levels in mice. Given these properties, Aβ42-IN-1 free base represents a potential disease-modifying agent for Alzheimer’s disease [1]. |
体内活性 | Aβ42-IN-1 free base treatment exhibits that the CL int value is 84.7 μL/min/mg protein [1]. Animal Model: Nonfasted 8-week-old male ddY mice [1] Dosage: 30 mg/kg Administration: p.o. (Pharmacokinetic Analysis) Result: The CL int is 84.7 μL/min/mg protein. |
分子量 | 462.54 |
分子式 | C29H26N4O2 |
CAS No. | 2434633-17-5 |
密度 | 1.20 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容